FVSKX
Price
$56.82
Change
+$0.64 (+1.14%)
Updated
Sep 26 closing price
Net Assets
1.74B
JVMCX
Price
$28.06
Change
+$0.28 (+1.01%)
Updated
Sep 26 closing price
Net Assets
24.25B
Interact to see
Advertisement

FVSKX vs JVMCX

Header iconFVSKX vs JVMCX Comparison
Open Charts FVSKX vs JVMCXBanner chart's image
Fidelity Value Strategies K
Price$56.82
Change+$0.64 (+1.14%)
VolumeN/A
Net Assets1.74B
JHancock Disciplined Value Mid Cap C
Price$28.06
Change+$0.28 (+1.01%)
VolumeN/A
Net Assets24.25B
FVSKX vs JVMCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FVSKX vs. JVMCX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVSKX is a Hold and JVMCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 24.2B vs. FVSKX (1.74B). FVSKX pays higher dividends than JVMCX: FVSKX (0.32) vs JVMCX (0.00). FVSKX was incepted earlier than JVMCX: FVSKX (17 years) vs JVMCX (14 years). JVMCX (1.86) is less costly to investors than FVSKX (0.72). FVSKX is a more actively managed with annual turnover of: 61.00 vs. JVMCX (49.00). FVSKX has a lower initial minimum investment than JVMCX: FVSKX (0) vs JVMCX (1000). JVMCX annual gain was more profitable for investors over the last year : -2.54 vs. FVSKX (-7.35). FVSKX return over 5 years is better than : 80.11 vs. JVMCX (54.71).
FVSKXJVMCXFVSKX / JVMCX
Total Expense Ratio0.721.8539%
Annual Report Gross Expense Ratio0.721.8639%
Fund Existence17 years14 years-
Gain YTD2.35010.90922%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.74B24.2B7%
Annual Yield % from dividends0.320.00-
Returns for 1 year-7.35-2.54290%
Returns for 3 years36.5230.96118%
Returns for 5 years80.1154.71146%
Returns for 10 years46.7850.9692%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NATBF0.23N/A
+0.88%
NATBRIDGE RES LTD
ASGLY6.500.01
+0.15%
AGC Inc.
FHGDF0.08N/A
N/A
Founder Holdings Ltd.
PBCRF0.45N/A
N/A
PT Bank Central Asia
RYHTY7.11N/A
N/A
Ryman Healthcare Ltd.